<?xml version="1.0" encoding="utf-8"?> <feed xmlns:dc="http://dublincore.org/documents/dcmi-namespace/" xmlns:media="http://search.yahoo.com/mrss/" xmlns="http://www.w3.org/2005/Atom"> <title type="text">Cognoa</title> <subtitle type="text">Contains the last 20 releases</subtitle> <id>uuid:651f8fe0-0f4d-4f06-9905-a3c764fd4fe5;id=8837</id> <rights type="text">Copyright 2020, Cognoa</rights> <updated>2020-09-23T13:03:00Z</updated> <author> <name>newsdesk@globenewswire.com (NewsDesk)</name> <uri>http://www.globenewswire.com/LegacyRss?Length=4</uri> <email>newsdesk@globenewswire.com</email> </author> <link rel="alternate" href="https://www.globenewswire.com/atomfeed/organization/GqdnSmUgd99OMzaWryaL8w==" /> <link rel="self" href="https://www.globenewswire.com/atomfeed/organization/GqdnSmUgd99OMzaWryaL8w==" /> <entry> <id>https://www.globenewswire.com/news-release/2020/09/23/2098045/0/en/Cognoa-Seeks-FDA-Clearance-for-Breakthrough-Digital-Autism-Diagnostic-Device-After-Successful-Pivotal-Study.html</id> <title type="text">Cognoa Seeks FDA Clearance for Breakthrough Digital Autism Diagnostic Device After Successful Pivotal Study</title> <published>2020-09-23T13:03:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/09/23/2098045/0/en/Cognoa-Seeks-FDA-Clearance-for-Breakthrough-Digital-Autism-Diagnostic-Device-After-Successful-Pivotal-Study.html" /> <content type="html"><![CDATA[Cognoa’s autism diagnostic device is positioned to be the first FDA-cleared digital solution enabling pediatricians to diagnose autism - a paradigm shift in the standard of care <pre>Cognoa’s autism diagnostic device is positioned to be the first FDA-cleared digital solution enabling pediatricians to diagnose autism - a paradigm shift in the standard of care</pre>]]></content> <dc:identifier>2098045</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Wed, 23 Sep 2020 13:03 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> <dc:subject>Health</dc:subject> <dc:subject>Press releases</dc:subject> <dc:subject>Regulatory information</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2020/03/24/2005312/0/en/Cognoa-Appoints-Industry-Leader-David-Happel-as-New-Chief-Executive-Officer.html</id> <title type="text">Cognoa Appoints Industry Leader David Happel as New Chief Executive Officer</title> <published>2020-03-24T10:05:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/03/24/2005312/0/en/Cognoa-Appoints-Industry-Leader-David-Happel-as-New-Chief-Executive-Officer.html" /> <content type="html"><![CDATA[Happel takes up the top job at Cognoa after over 25 years of successfully commercializing medical products and as a leader in the biotech and biopharma industries <pre>Happel takes up the top job at Cognoa after over 25 years of successfully commercializing medical products and as a leader in the biotech and biopharma industries</pre>]]></content> <dc:identifier>2005312</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Tue, 24 Mar 2020 10:05 GMT</dc:modified> <media:content medium="image" type="image/png" width="600" url="https://ml.globenewswire.com/Resource/Download/90ffce06-565f-4cf1-900c-701984419653"> <media:text type="html"><![CDATA[<p> <a href="https://www.globenewswire.com/news-release/2020/03/24/2005312/0/en/Cognoa-Appoints-Industry-Leader-David-Happel-as-New-Chief-Executive-Officer.html"> <img src="https://ml.globenewswire.com/Resource/Download/90ffce06-565f-4cf1-900c-701984419653" width="600" align="left" border="0" alt="Photo" title="Cognoa appoints industry leader David Happel as new Chief Executive Officer. Happel takes up the top job at Cognoa after over 25 years of successfully commercializing medical products and as a leader in the biotech and biopharma industries. " /> </a> </p><br clear="all" />]]></media:text> <media:credit role="publishing company">GlobeNewswire Inc.</media:credit> </media:content> <dc:subject>Company Announcement</dc:subject> <dc:subject>Press releases</dc:subject> <dc:keyword>pediatric behavioral health</dc:keyword> <dc:keyword>digital therapeutics</dc:keyword> <dc:keyword>digital diagnostics</dc:keyword> <dc:keyword>autism</dc:keyword> <dc:keyword>early intervention</dc:keyword> <dc:keyword>behavioral health</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2020/03/05/1995917/0/en/Cognoa-Appoints-Dr-Colleen-Kraft-Senior-Medical-Director-of-Clinical-Adoption.html</id> <title type="text">Cognoa Appoints Dr. Colleen Kraft Senior Medical Director of Clinical Adoption</title> <published>2020-03-05T14:03:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/03/05/1995917/0/en/Cognoa-Appoints-Dr-Colleen-Kraft-Senior-Medical-Director-of-Clinical-Adoption.html" /> <content type="html"><![CDATA[AAP 2018 Past President Joins Cognoa to Improve the Standard of Care for Children with Autism Through Greater Pediatrician Adoption of Digital Prescription Apps <pre>AAP 2018 Past President Joins Cognoa to Improve the Standard of Care for Children with Autism Through Greater Pediatrician Adoption of Digital Prescription Apps</pre>]]></content> <dc:identifier>1995917</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Thu, 05 Mar 2020 14:03 GMT</dc:modified> <media:content medium="image" type="image/jpeg" width="600" url="https://ml.globenewswire.com/Resource/Download/378fb37b-8242-4013-a4b1-4292e2690389"> <media:text type="html"><![CDATA[<p> <a href="https://www.globenewswire.com/news-release/2020/03/05/1995917/0/en/Cognoa-Appoints-Dr-Colleen-Kraft-Senior-Medical-Director-of-Clinical-Adoption.html"> <img src="https://ml.globenewswire.com/Resource/Download/378fb37b-8242-4013-a4b1-4292e2690389" width="600" align="left" border="0" alt="Photo" title="AAP 2018 Past President, Dr. Colleen Kraft, Joins Cognoa to Improve the Standard of Care for Children with Autism Through Greater Pediatrician Adoption of Digital Prescription Apps" /> </a> </p><br clear="all" />]]></media:text> <media:credit role="publishing company">GlobeNewswire Inc.</media:credit> </media:content> <dc:subject>Company Announcement</dc:subject> <dc:subject>Press releases</dc:subject> <dc:keyword>Digital Therapeutics</dc:keyword> <dc:keyword>Pediatric Behavioral Health</dc:keyword> <dc:keyword>Autism</dc:keyword> <dc:keyword>#putkids1st</dc:keyword> <dc:keyword>#earlyintervention</dc:keyword> <dc:keyword>@AmerAcadPeds</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2020/02/26/1991052/0/en/Cognoa-CEO-to-Participate-in-the-Cowen-and-Company-40th-Annual-Healthcare-Conference.html</id> <title type="text">Cognoa CEO to Participate in the Cowen and Company 40th Annual Healthcare Conference</title> <published>2020-02-26T14:05:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/02/26/1991052/0/en/Cognoa-CEO-to-Participate-in-the-Cowen-and-Company-40th-Annual-Healthcare-Conference.html" /> <content type="html"><![CDATA[<p>Palo Alto, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=kQXDuoYmL8Z_hX4RSt-z534agalkLWo8SYu0habUURUgUxMIbwabOqb0GXvibgFiMLqQay41O_BVH7dUfQvEjQ==" rel="nofollow" target="_blank" title="Cognoa">Cognoa</a>, the leading digital therapeutics company focused on pediatric behavioral health, announced today that CEO, Brent Vaughan, will participate in a digital therapeutics panel discussion at the Cowen and Company 40th Annual Healthcare Conference with executives from Akili Interactive Labs, Click Therapeutics and Pear Therapeutics. The panel will take place at 1:30 p.m. EST on Tuesday, March 3, at the Boston Marriott Copley Place.</p>]]></content> <dc:identifier>1991052</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Wed, 26 Feb 2020 14:05 GMT</dc:modified> <media:content medium="image" type="image/jpeg" width="600" url="https://ml.globenewswire.com/Resource/Download/4257e6ec-eb36-4457-afd4-031d37455daa"> <media:text type="html"><![CDATA[<p> <a href="https://www.globenewswire.com/news-release/2020/02/26/1991052/0/en/Cognoa-CEO-to-Participate-in-the-Cowen-and-Company-40th-Annual-Healthcare-Conference.html"> <img src="https://ml.globenewswire.com/Resource/Download/4257e6ec-eb36-4457-afd4-031d37455daa" width="600" align="left" border="0" alt="Photo" title="Brent Vaughan, CEO and Co-Founder of Cognoa, will participate in a digital therapeutics panel discussion at the Cowen and Company 40th Annual Healthcare Conference at 1:30 p.m. EST on Tuesday, March 3, at the Boston Marriott Copley Place." /> </a> </p><br clear="all" />]]></media:text> <media:credit role="publishing company">GlobeNewswire Inc.</media:credit> </media:content> <dc:subject>Calendar of Events</dc:subject> <dc:subject>Company Announcement</dc:subject> <dc:subject>Press releases</dc:subject> <dc:keyword>digital therapeutics</dc:keyword> <dc:keyword>digital health</dc:keyword> <dc:keyword>healthcare</dc:keyword> <dc:keyword>#cowenhealthcare</dc:keyword> <dc:keyword>pediatrics</dc:keyword> <dc:keyword>behavioral health</dc:keyword> <dc:keyword>healthtech</dc:keyword> <dc:keyword>AI</dc:keyword> <dc:keyword>mhealth</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2020/02/11/1983107/0/en/Autism-Learning-Partners-and-Cognoa-Announce-Partnership-to-Enable-Earlier-Access-to-Care.html</id> <title type="text">Autism Learning Partners and Cognoa Announce Partnership to Enable Earlier Access to Care</title> <published>2020-02-11T14:00:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/02/11/1983107/0/en/Autism-Learning-Partners-and-Cognoa-Announce-Partnership-to-Enable-Earlier-Access-to-Care.html" /> <content type="html"><![CDATA[<p>PASADENA and PALO ALTO, Calif., Feb. 11, 2020 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6r5wWKRNy0avSliXy_FpUTs7D2vqgxkKA2OBqIlt-9TvlNHjevhh-Owq-8EPx8jlxhbJN8BzMHPg2UMGS_WlalMWvHlqigwJb7jNMhMJ1Xy_YOUyMBbbP2U7FKDi_M0K" rel="nofollow" target="_blank" title="Autism Learning Partners">Autism Learning Partners</a> ("ALP"), a national leader in the treatment of autism and other developmental disabilities, and <a href="https://www.globenewswire.com/Tracker?data=2awkfYuFaVIeTLbvtLKUdyRX2cKwjECsppjiKxn7Pp-mhz4Xn_37CTnUXEuggQ76EiZ69RKeErDhQ0JYkQbvPg==" rel="nofollow" target="_blank" title="Cognoa">Cognoa</a>, the leading digital therapeutics company focused on pediatric behavioral health, announced today a partnership designed to accelerate the diagnosis of autism to enable interventions earlier, when there is the greatest potential to improve lifelong outcomes.</p>]]></content> <dc:identifier>1983107</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Tue, 11 Feb 2020 14:01 GMT</dc:modified> <media:content medium="image" type="image/png" width="600" url="https://ml.globenewswire.com/Resource/Download/1cc2a29e-0ea5-4e65-9e0a-fefc8cf9101a"> <media:text type="html"><![CDATA[<p> <a href="https://www.globenewswire.com/news-release/2020/02/11/1983107/0/en/Autism-Learning-Partners-and-Cognoa-Announce-Partnership-to-Enable-Earlier-Access-to-Care.html"> <img src="https://ml.globenewswire.com/Resource/Download/1cc2a29e-0ea5-4e65-9e0a-fefc8cf9101a" width="600" align="left" border="0" alt="Photo" title="Autism Learning Partners and Cognoa Announce Partnership to Enable Earlier Access to Care 
" /> </a> </p><br clear="all" />]]></media:text> <media:credit role="publishing company">GlobeNewswire Inc.</media:credit> </media:content> <dc:subject>Company Announcement</dc:subject> <dc:keyword>autism</dc:keyword> <dc:keyword>digital therapeutics</dc:keyword> <dc:keyword>digital medicines</dc:keyword> <dc:keyword>Cognoa</dc:keyword> <dc:keyword>ABA Therapy</dc:keyword> <dc:keyword>early diagnosis</dc:keyword> <dc:keyword>pediatrics</dc:keyword> <dc:keyword>pediatric behavioral health</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2020/02/10/1982378/0/en/Cognoa-Executives-to-Speak-at-DTx-West-2020.html</id> <title type="text">Cognoa Executives to Speak at DTx West 2020</title> <published>2020-02-10T14:00:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/02/10/1982378/0/en/Cognoa-Executives-to-Speak-at-DTx-West-2020.html" /> <content type="html"><![CDATA[<p>Palo Alto, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=KxTGhUjezY6jtz-lea4LzYrP33PRF1riBrHtXAbGncYPZ_2960Kdr3Cn0MXazMEwsJlvRcsPYDNEBUdl2mM3NQ==" rel="nofollow" target="_blank" title="Cognoa">Cognoa</a>, the leading digital therapeutics company focused on pediatric behavioral health, announced today that three company executives will be on stage at the third annual<a href="https://www.globenewswire.com/Tracker?data=ZfGkmVbItZ9vDNYiuYDcIIvozMIGSRZCi_RPDDkUy70DmNgbLq2wC6Cn03EQYkQa-ST0ZdLhEpWsjPSdB3UMHQ==" rel="nofollow" target="_blank" title="DTx West 2020"> DTx West 2020</a>, taking place in San Mateo, California, February 18 to 20. </p>]]></content> <dc:identifier>1982378</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Mon, 10 Feb 2020 15:49 GMT</dc:modified> <media:content medium="image" type="image/jpeg" width="600" url="https://ml.globenewswire.com/Resource/Download/ffd82331-2af5-4ebc-b30d-90e05a7e0ccb"> <media:text type="html"><![CDATA[<p> <a href="https://www.globenewswire.com/news-release/2020/02/10/1982378/0/en/Cognoa-Executives-to-Speak-at-DTx-West-2020.html"> <img src="https://ml.globenewswire.com/Resource/Download/ffd82331-2af5-4ebc-b30d-90e05a7e0ccb" width="600" align="left" border="0" alt="Photo" title="Brent Vaughan, CEO and co-founder, Cognoa" /> </a> </p><br clear="all" />]]></media:text> <media:credit role="publishing company">GlobeNewswire Inc.</media:credit> </media:content> <dc:subject>Company Announcement</dc:subject> <dc:keyword>Cognoa</dc:keyword> <dc:keyword>#DTxWest</dc:keyword> <dc:keyword>autism</dc:keyword> <dc:keyword>digital therapeutics</dc:keyword> <dc:keyword>pediatric behavioral health</dc:keyword> <dc:keyword>digital health</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2020/01/29/1976820/0/en/Cognoa-Named-to-the-2020-Global-Digital-Health-100-By-The-Journal-of-mHealth.html</id> <title type="text">Cognoa Named to the 2020 Global Digital Health 100 By The Journal of mHealth</title> <published>2020-01-29T14:00:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/01/29/1976820/0/en/Cognoa-Named-to-the-2020-Global-Digital-Health-100-By-The-Journal-of-mHealth.html" /> <content type="html"><![CDATA[International Health Technology Publication Annual List Recognizes Innovation and Leaders in Health Technology <pre>International Health Technology Publication Annual List Recognizes Innovation and Leaders in Health Technology</pre>]]></content> <dc:identifier>1976820</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Wed, 29 Jan 2020 14:00 GMT</dc:modified> <media:content medium="image" type="image/jpeg" width="600" url="https://ml.globenewswire.com/Resource/Download/0622a232-ffac-4fe6-9b17-957aa3031871"> <media:text type="html"><![CDATA[<p> <a href="https://www.globenewswire.com/news-release/2020/01/29/1976820/0/en/Cognoa-Named-to-the-2020-Global-Digital-Health-100-By-The-Journal-of-mHealth.html"> <img src="https://ml.globenewswire.com/Resource/Download/0622a232-ffac-4fe6-9b17-957aa3031871" width="600" align="left" border="0" alt="Photo" title="Cognoa is named a 2020 Global Digital Health 100 Company by The Journal of mHealth" /> </a> </p><br clear="all" />]]></media:text> <media:credit role="publishing company">GlobeNewswire Inc.</media:credit> </media:content> <dc:subject>Company Announcement</dc:subject> <dc:subject>Health</dc:subject> <dc:keyword>Digital health</dc:keyword> <dc:keyword>pediatric behavioral health</dc:keyword> <dc:keyword>Global Digital Health 100</dc:keyword> <dc:keyword>Cognoa</dc:keyword> <dc:keyword>Digital therapeutics</dc:keyword> <dc:keyword>autism</dc:keyword> <dc:keyword>pediatricians</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2020/01/24/1974688/0/en/UPDATED-Austin-Regional-Clinic-Recruiting-Families-for-Clinical-Trial-Testing-Mobile-Device-to-Aid-Autism-Diagnosis-in-Young-Children.html</id> <title type="text">UPDATED: Austin Regional Clinic Recruiting Families for Clinical Trial Testing Mobile Device to Aid Autism Diagnosis in Young Children</title> <published>2020-01-24T01:38:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/01/24/1974688/0/en/UPDATED-Austin-Regional-Clinic-Recruiting-Families-for-Clinical-Trial-Testing-Mobile-Device-to-Aid-Autism-Diagnosis-in-Young-Children.html" /> <content type="html"><![CDATA[Cognoa’s Autism Diagnostic is Designed for Pediatricians to Use with Children as Young as 18 Months <pre>Cognoa’s Autism Diagnostic is Designed for Pediatricians to Use with Children as Young as 18 Months</pre>]]></content> <dc:identifier>1974688</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Fri, 24 Jan 2020 01:37 GMT</dc:modified> <media:content medium="image" type="image/png" width="600" url="https://ml.globenewswire.com/Resource/Download/e2d09d83-1e8e-45e2-8606-4cba18ed95c4"> <media:text type="html"><![CDATA[<p> <a href="https://www.globenewswire.com/news-release/2020/01/24/1974688/0/en/UPDATED-Austin-Regional-Clinic-Recruiting-Families-for-Clinical-Trial-Testing-Mobile-Device-to-Aid-Autism-Diagnosis-in-Young-Children.html"> <img src="https://ml.globenewswire.com/Resource/Download/e2d09d83-1e8e-45e2-8606-4cba18ed95c4" width="600" align="left" border="0" alt="Photo" title="Austin Regional Clinic (ARC) is a multispecialty medical group committed to providing comprehensive healthcare services throughout the greater Austin area. Founded by three physicians in 1980, ARC now provides health care to over 500,000 area residents in 27 locations in 11 cities, including both primary and specialty care. ARC is unique to the Central Texas area because of the widespread locations, convenient services, and quality assurance programs. ARC patients enjoy access to such conveniences as same-day appointments, 24/7 online and phone appointment scheduling, ARC MyChart patient portal, After Hours Clinics, and nursing services through the night. Most ARC clinics also offer on-site radiology and lab services and some clinics offer specialty programs such as a travel clinic and Healthiness program. For more information, visit www.austinregionalclinic.com." /> </a> </p><br clear="all" />]]></media:text> <media:credit role="publishing company">GlobeNewswire Inc.</media:credit> </media:content> <dc:subject>Health</dc:subject> <dc:keyword>autism</dc:keyword> <dc:keyword>digital therapeutics</dc:keyword> <dc:keyword>digital medicines</dc:keyword> <dc:keyword>pediatric behavioral health</dc:keyword> <dc:keyword>DTX</dc:keyword> <dc:keyword>Cognoa</dc:keyword> <dc:keyword>Austin Regional Clinic</dc:keyword> <dc:keyword>clinical trial</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2020/01/23/1974508/0/en/Austin-Regional-Clinic-Recruiting-Families-for-Clinical-Trial-Testing-Mobile-Device-to-Aid-Autism-Diagnosis-in-Young-Children.html</id> <title type="text">Austin Regional Clinic Recruiting Families for Clinical Trial Testing Mobile Device to Aid Autism Diagnosis in Young Children</title> <published>2020-01-23T17:54:26Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/01/23/1974508/0/en/Austin-Regional-Clinic-Recruiting-Families-for-Clinical-Trial-Testing-Mobile-Device-to-Aid-Autism-Diagnosis-in-Young-Children.html" /> <content type="html"><![CDATA[Cognoa’s Autism Diagnostic is Designed for Pediatricians to Use with Children as Young as 18 Months <pre>Cognoa’s Autism Diagnostic is Designed for Pediatricians to Use with Children as Young as 18 Months</pre>]]></content> <dc:identifier>1974508</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Thu, 23 Jan 2020 17:54 GMT</dc:modified> <media:content medium="image" type="image/png" width="600" url="https://ml.globenewswire.com/Resource/Download/c094a5c8-fd10-452c-bd58-10d3ef687eea"> <media:text type="html"><![CDATA[<p> <a href="https://www.globenewswire.com/news-release/2020/01/23/1974508/0/en/Austin-Regional-Clinic-Recruiting-Families-for-Clinical-Trial-Testing-Mobile-Device-to-Aid-Autism-Diagnosis-in-Young-Children.html"> <img src="https://ml.globenewswire.com/Resource/Download/c094a5c8-fd10-452c-bd58-10d3ef687eea" width="600" align="left" border="0" alt="Photo" title="Austin Regional Clinic (ARC) is a multispecialty medical group committed to providing comprehensive healthcare services throughout the greater Austin area. Founded by three physicians in 1980, ARC now provides health care to over 500,000 area residents in 27 locations in 11 cities, including both primary and specialty care. ARC is unique to the Central Texas area because of the widespread locations, convenient services, and quality assurance programs. ARC patients enjoy access to such conveniences as same-day appointments, 24/7 online and phone appointment scheduling, ARC MyChart patient portal, After Hours Clinics, and nursing services through the night. Most ARC clinics also offer on-site radiology and lab services and some clinics offer specialty programs such as a travel clinic and Healthiness program. For more information, visit www.austinregionalclinic.com." /> </a> </p><br clear="all" />]]></media:text> <media:credit role="publishing company">GlobeNewswire Inc.</media:credit> </media:content> <dc:subject>Health</dc:subject> <dc:keyword>autism</dc:keyword> <dc:keyword>digital therapeutics</dc:keyword> <dc:keyword>digital medicines</dc:keyword> <dc:keyword>pediatric behavioral health</dc:keyword> <dc:keyword>DTX</dc:keyword> <dc:keyword>Cognoa</dc:keyword> <dc:keyword>Austin Regional Clinic</dc:keyword> <dc:keyword>clinical trial</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2020/01/06/1966474/0/en/Cognoa-CEO-and-CMO-Presenting-at-Digital-Medicine-Medtech-Showcase-2020-and-InnovatorMD-Global-Summit-in-San-Francisco.html</id> <title type="text">Cognoa CEO and CMO Presenting at Digital Medicine & Medtech Showcase 2020 and InnovatorMD Global Summit in San Francisco</title> <published>2020-01-06T13:30:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/01/06/1966474/0/en/Cognoa-CEO-and-CMO-Presenting-at-Digital-Medicine-Medtech-Showcase-2020-and-InnovatorMD-Global-Summit-in-San-Francisco.html" /> <content type="html"><![CDATA[<p>PALO ALTO, Calif., Jan. 06, 2020 (GLOBE NEWSWIRE) -- <u><a href="https://www.globenewswire.com/Tracker?data=WPc1wa6mtstRu27TdU1bPQ13HFeqI8tsAchlDeK8uRhrQ4OMQfmdwvQOKfw_SS1rS2scUkygZUSUZ39MscLdBg==" rel="nofollow" target="_blank" title="Cognoa">Cognoa</a></u>, the leading digital therapeutics company focused on pediatric behavioral health, announced today that senior executives will be speaking at two healthcare innovation and investor conferences in San Francisco.<br></p>]]></content> <dc:identifier>1966474</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Mon, 06 Jan 2020 13:30 GMT</dc:modified> <dc:subject>Calendar of Events</dc:subject> <dc:subject>Company Announcement</dc:subject> <dc:keyword>digital therapeutics</dc:keyword> <dc:keyword>autism</dc:keyword> <dc:keyword>digital medicines</dc:keyword> <dc:keyword>pediatric behavioral health</dc:keyword> <dc:keyword>#DigiMedShow</dc:keyword> <dc:keyword>#JPM20</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2019/12/18/1962445/0/en/Cognoa-Wins-2019-Fierce-Innovation-Life-Science-Award.html</id> <title type="text">Cognoa Wins 2019 Fierce Innovation Life Science Award</title> <published>2019-12-18T20:05:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2019/12/18/1962445/0/en/Cognoa-Wins-2019-Fierce-Innovation-Life-Science-Award.html" /> <content type="html"><![CDATA[<p>Palo Alto, Calif., Dec. 18, 2019 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=ShJfftAooqnPBjwOpE1cOmzjOlGhYDwrndVtuj0FHaWcRxM-MAuI6AbiihlOYsQEQ91y8HKQ9e1PBvK9hVplTA==" rel="nofollow" target="_blank" title="Cognoa">Cognoa</a>, a company at the forefront of pediatric behavioral health, has won the <a href="https://www.globenewswire.com/Tracker?data=lmv8yfKVAPY47H41-1NbAVb9OGCmd6_OQcjZSENFXnGzUiRDoi44wRKS_d7TkO9J9LO2zA07Xt8553r_RSBQb6cM90SWXk4A9_fT5YpMf6W0Lyh4pvDvQYB-wrj16fJBGh6yK5n1XEBSPS4xQkbFlscrUYRFdvyLn3ggC4GM_C5mOqZYDFYPwnnO1Eb5_y4x" rel="nofollow" target="_blank" title="Fierce Innovation Life Science Award">Fierce Innovation Life Science Award</a> for Technology Innovation. Cognoa’s digital therapeutics will advance the standard of care by giving every child the opportunity to receive treatments earlier when they can have the greatest impact.</p>]]></content> <dc:identifier>1962445</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Wed, 18 Dec 2019 22:10 GMT</dc:modified> <media:content medium="image" type="image/png" width="600" url="https://ml.globenewswire.com/Resource/Download/e84a7072-6373-49f7-ac80-0c6cb665e8f2"> <media:text type="html"><![CDATA[<p> <a href="https://www.globenewswire.com/news-release/2019/12/18/1962445/0/en/Cognoa-Wins-2019-Fierce-Innovation-Life-Science-Award.html"> <img src="https://ml.globenewswire.com/Resource/Download/e84a7072-6373-49f7-ac80-0c6cb665e8f2" width="600" align="left" border="0" alt="Photo" title="Cognoa, a company at the forefront of pediatric behavioral health, has won the Fierce Innovation Life Sciences Award for Technology Innovation. Cognoa’s digital therapeutics will advance the standard of care by giving every child the opportunity to receive treatments earlier when they can have the greatest impact. Cognoa’s digital therapeutics and medicines will provide a continuum of care from identifying at-risk children to empowering early diagnosis and treatment of behavioral health conditions. By targeting the critical, early neurodevelopmental windows, Cognoa’s digital therapeutics promote neuromodulation of specific brain networks, improving functional connectivity to create lifelong gains. More information is available at: https://www.cognoa.com/ " /> </a> </p><br clear="all" />]]></media:text> <media:credit role="publishing company">GlobeNewswire Inc.</media:credit> </media:content> <dc:subject>Company Announcement</dc:subject> <dc:subject>Health</dc:subject> <dc:keyword>digital therapeutics</dc:keyword> <dc:keyword>digital medicine</dc:keyword> <dc:keyword>Fierce Innovation Awards</dc:keyword> <dc:keyword>autism</dc:keyword> <dc:keyword>Cognoa</dc:keyword> <dc:keyword>digital diagnostic</dc:keyword> <dc:keyword>AI</dc:keyword> <dc:keyword>pediatricians</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2019/12/05/1956854/0/en/COGNOA-SELECTED-AS-FINALIST-IN-FIERCE-INNOVATION-AWARDS-LIFE-SCIENCES-EDITION-2019.html</id> <title type="text">COGNOA SELECTED AS FINALIST IN FIERCE INNOVATION AWARDS – LIFE SCIENCES EDITION 2019</title> <published>2019-12-05T14:15:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2019/12/05/1956854/0/en/COGNOA-SELECTED-AS-FINALIST-IN-FIERCE-INNOVATION-AWARDS-LIFE-SCIENCES-EDITION-2019.html" /> <content type="html"><![CDATA[Cognoa develops AI-powered digital therapeutics and medicines that advance the standard of care in pediatric behavioral health and improve lifelong outcomes for children <pre>Cognoa develops AI-powered digital therapeutics and medicines that advance the standard of care in pediatric behavioral health and improve lifelong outcomes for children</pre>]]></content> <dc:identifier>1956854</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Thu, 05 Dec 2019 14:15 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> <dc:subject>Health</dc:subject> <dc:keyword>Cognoa</dc:keyword> <dc:keyword>Fierce Innovation Awards</dc:keyword> <dc:keyword>Digital Therapeutics</dc:keyword> <dc:keyword>AI in medicine</dc:keyword> <dc:keyword>digital medicines</dc:keyword> <dc:keyword>autism</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2019/12/02/1954805/0/en/COGNOA-APPOINTS-SEASONED-BIOTECH-EXECUTIVE-AS-CFO.html</id> <title type="text">COGNOA APPOINTS SEASONED BIOTECH EXECUTIVE AS CFO</title> <published>2019-12-02T13:55:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2019/12/02/1954805/0/en/COGNOA-APPOINTS-SEASONED-BIOTECH-EXECUTIVE-AS-CFO.html" /> <content type="html"><![CDATA[James Welch brings two decades experience scaling high-growth companies to Cognoa as company prepares for commercialization <pre>James Welch brings two decades experience scaling high-growth companies to Cognoa as company prepares for commercialization</pre>]]></content> <dc:identifier>1954805</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Mon, 02 Dec 2019 13:55 GMT</dc:modified> <media:content medium="image" type="image/png" width="600" url="https://ml.globenewswire.com/Resource/Download/ccce2377-7be8-4deb-a2b6-13d6c886cb3f"> <media:text type="html"><![CDATA[<p> <a href="https://www.globenewswire.com/news-release/2019/12/02/1954805/0/en/COGNOA-APPOINTS-SEASONED-BIOTECH-EXECUTIVE-AS-CFO.html"> <img src="https://ml.globenewswire.com/Resource/Download/ccce2377-7be8-4deb-a2b6-13d6c886cb3f" width="600" align="left" border="0" alt="Photo" title="James (Jim) H. Welch has been appointed CFO of Cognoa. Welch will oversee financial planning, operations and investor relations as the company advances its digital therapeutics and digital medicines towards commercialization in 2020. Welch has an impressive 20-year track record of success guiding emerging biotech companies—managing two IPOs, as well as raising a combined total of $800M in support of research, development, and preparation for commercialization. “We are delighted to have Jim join the Cognoa leadership team. Jim’s experience and expertise scaling high-growth biotech companies make him the ideal CFO for Cognoa as we look to gain FDA clearance and commercialize our pipeline of prescription digital therapeutics,” said Brent Vaughan, co-founder, and CEO of Cognoa. " /> </a> </p><br clear="all" />]]></media:text> <media:credit role="publishing company">GlobeNewswire Inc.</media:credit> </media:content> <dc:subject>Company Announcement</dc:subject> <dc:subject>Health</dc:subject> <dc:keyword>Digital Therapeutics</dc:keyword> <dc:keyword>autism</dc:keyword> <dc:keyword>pediatric Behavioral Health</dc:keyword> <dc:keyword>CFO</dc:keyword> <dc:keyword>Commercialization</dc:keyword> <dc:keyword>Cognoa</dc:keyword> <dc:keyword>digital medicines</dc:keyword> <dc:keyword>biotech</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2019/11/14/1947500/0/en/COGNOA-TO-PARTICIPATE-IN-BTIG-DIGITAL-HEALTH-AND-EVERCORE-ISI-HealthCONx-CONFERENCES.html</id> <title type="text">COGNOA TO PARTICIPATE IN BTIG DIGITAL HEALTH AND EVERCORE ISI HealthCONx CONFERENCES</title> <published>2019-11-14T18:07:32Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2019/11/14/1947500/0/en/COGNOA-TO-PARTICIPATE-IN-BTIG-DIGITAL-HEALTH-AND-EVERCORE-ISI-HealthCONx-CONFERENCES.html" /> <content type="html"><![CDATA[<p>Palo Alto, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=VdQhgbUk-ibvYWY9NjN4ZsGptDzyjYzNT3pilLSOZaKLIuDmCmH8m_FTLAvgSZT3qO07mXbhvv2jDfGGOaVibw==" rel="nofollow" target="_blank" title="Cognoa">Cognoa</a>, a company at the forefront of pediatric behavioral health, announced today that CEO Brent Vaughan will be speaking at two upcoming investor conferences:</p>]]></content> <dc:identifier>1947500</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Thu, 14 Nov 2019 19:21 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> <dc:subject>Health</dc:subject> <dc:keyword>autism</dc:keyword> <dc:keyword>digital therapeutics</dc:keyword> <dc:keyword>digital medicines</dc:keyword> <dc:keyword>Investor conference</dc:keyword> <dc:keyword>healthtech</dc:keyword> <dc:keyword>behavioral health</dc:keyword> <dc:keyword>pediatric behavioral health</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2019/10/28/1936418/0/en/Cognoa-CEO-Brent-Vaughan-to-Speak-at-HLTH-and-CNS-Summit.html</id> <title type="text">Cognoa CEO Brent Vaughan to Speak at HLTH and CNS Summit</title> <published>2019-10-28T14:00:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2019/10/28/1936418/0/en/Cognoa-CEO-Brent-Vaughan-to-Speak-at-HLTH-and-CNS-Summit.html" /> <content type="html"><![CDATA[<p>Palo Alto, Calif. and Orlando, Oct. 28, 2019 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=427ypsHCdtRyPPWHN0arqZ237vmR4Dd604JMw0c0CyMDGytamJubovBx39zhCcX_OB1wr8N9fAusdOO00HaElg==" rel="nofollow" target="_blank" title="Cognoa">Cognoa</a>, a company at the forefront of pediatric behavioral health, announced today that CEO Brent Vaughan will be speaking about the future of digital therapeutics at two conferences this week, HLTH and CNS Summit. Andy Molnar, Vice President of Commercialization at Cognoa will also speak at HLTH about reimbursement strategies for digital therapeutics.</p>]]></content> <dc:identifier>1936418</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Mon, 28 Oct 2019 15:02 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> <dc:subject>Health</dc:subject> <dc:subject>Trade Show</dc:subject> <dc:keyword>#HLTH2019</dc:keyword> <dc:keyword>CNS Summit</dc:keyword> <dc:keyword>digital therapeutics</dc:keyword> <dc:keyword>autism</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2019/10/24/1935017/0/en/Cognoa-Launches-Pivotal-Study-of-the-First-Digital-Diagnostic-for-Autism.html</id> <title type="text">Cognoa Launches Pivotal Study of the First Digital Diagnostic for Autism</title> <published>2019-10-24T13:00:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2019/10/24/1935017/0/en/Cognoa-Launches-Pivotal-Study-of-the-First-Digital-Diagnostic-for-Autism.html" /> <content type="html"><![CDATA[Pivotal Study Results Will be Basis of a Premarket Submission to FDA <pre>Pivotal Study Results Will be Basis of a Premarket Submission to FDA</pre>]]></content> <dc:identifier>1935017</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Thu, 24 Oct 2019 15:45 GMT</dc:modified> <dc:subject>Health</dc:subject> <dc:subject>Product / Services Announcement</dc:subject> <dc:subject>Press releases</dc:subject> <dc:keyword>Digital Therapeutics</dc:keyword> <dc:keyword>digital medicine</dc:keyword> <dc:keyword>autism</dc:keyword> <dc:keyword>Diagnostics</dc:keyword> <dc:keyword>pediatric behavioral health</dc:keyword> <dc:keyword>FDA</dc:keyword> <dc:keyword>clinical study</dc:keyword> <dc:keyword>pediatricians</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2019/04/10/1802043/0/en/Cognoa-Licenses-Innovative-Digital-Therapeutic-Technology.html</id> <title type="text">Cognoa Licenses Innovative Digital Therapeutic Technology</title> <published>2019-04-10T13:04:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2019/04/10/1802043/0/en/Cognoa-Licenses-Innovative-Digital-Therapeutic-Technology.html" /> <content type="html"><![CDATA[Technology will be productized into readily accessible digital applications and incorporated into Cognoa’s precision health platform <pre>Technology will be productized into readily accessible digital applications and incorporated into Cognoa’s precision health platform</pre>]]></content> <dc:identifier>1802043</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Wed, 10 Apr 2019 13:04 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> <dc:keyword>Cognoa</dc:keyword> <dc:keyword>Stanford</dc:keyword> <dc:keyword>autism</dc:keyword> <dc:keyword>autism spectrum disorder</dc:keyword> <dc:keyword>artificial intelligence</dc:keyword> <dc:keyword>machine learning</dc:keyword> <dc:keyword>google glass</dc:keyword> <dc:keyword>medical device</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2019/02/06/1711471/0/en/Cognoa-Receives-FDA-Breakthrough-Designations-for-Autism-Diagnostic-and-Digital-Therapeutic-Devices.html</id> <title type="text">Cognoa Receives FDA Breakthrough Designations for Autism Diagnostic and Digital Therapeutic Devices</title> <published>2019-02-06T14:04:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2019/02/06/1711471/0/en/Cognoa-Receives-FDA-Breakthrough-Designations-for-Autism-Diagnostic-and-Digital-Therapeutic-Devices.html" /> <content type="html"><![CDATA[Company announces first digital therapeutic device and precision health platform to support the developmental and behavioral health of children <pre>Company announces first digital therapeutic device and precision health platform to support the developmental and behavioral health of children</pre>]]></content> <dc:identifier>1711471</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Wed, 06 Feb 2019 14:04 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> <dc:keyword>Cognoa</dc:keyword> <dc:keyword>child development</dc:keyword> <dc:keyword>child health</dc:keyword> <dc:keyword>diagnostics</dc:keyword> <dc:keyword>therapeutics</dc:keyword> <dc:keyword>digital health</dc:keyword> <dc:keyword>autism</dc:keyword> <dc:keyword>autism spectrum disorder</dc:keyword> <dc:keyword>behavioral health</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2019/01/08/1682126/0/en/Cognoa-Selected-by-Cambia-Health-Solutions-to-Provide-Support-for-Employees-Raising-Young-Children.html</id> <title type="text">Cognoa Selected by Cambia Health Solutions to Provide Support for Employees Raising Young Children</title> <published>2019-01-08T14:03:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2019/01/08/1682126/0/en/Cognoa-Selected-by-Cambia-Health-Solutions-to-Provide-Support-for-Employees-Raising-Young-Children.html" /> <content type="html"><![CDATA[<p align="left">PALO ALTO, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Zca9kFK_e55cpxudjaUYO7Hb9acnNOxxTLPNP1MiiE7_-bW_mmYiSbgRw_uLqW51y8q1DBGDYq3chIn05g-Bxw==" rel="nofollow" target="_blank" title=""><u>Cognoa</u></a>, a digital behavioral health company, announced today that <a href="https://www.globenewswire.com/Tracker?data=abb68BirGQnPQBolwuf8B1er_MlO_1lnoGjW582IQuF-DLezrgczAeNHivwK1JJQSYXSDsFSU-mmNY2pz2U4atNLcod0ag2zaUc5OJCDFdQ=" rel="nofollow" target="_blank" title=""><u>Cambia Health Solutions, Inc</u></a>. (Cambia) is incorporating Cognoa’s evidence-based platform within its subsidiary health plans. Cognoa provides support for employees caring for children older than one. Cognoa offers reliable guidance on day-to-day challenges and personalized resources that enable parents to assess, track, and positively impact their children’s unique developmental growth.<br></p>]]></content> <dc:identifier>1682126</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Tue, 08 Jan 2019 14:03 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> <dc:keyword>Cognoa</dc:keyword> <dc:keyword>employees</dc:keyword> <dc:keyword>employee benefits</dc:keyword> <dc:keyword>Enterprise</dc:keyword> <dc:keyword>human resources</dc:keyword> <dc:keyword>autism</dc:keyword> <dc:keyword>autism spectrum disorder</dc:keyword> <dc:keyword>employers</dc:keyword> <dc:keyword>machine learning</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2018/11/15/1652376/0/en/LEARN-Behavioral-Announces-Partnership-with-Cognoa-to-Empower-Parents-and-Enable-Earlier-Diagnosis.html</id> <title type="text">LEARN Behavioral Announces Partnership with Cognoa to Empower Parents and Enable Earlier Diagnosis</title> <published>2018-11-15T14:04:00Z</published> <updated>2024-11-23T17:27:38Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2018/11/15/1652376/0/en/LEARN-Behavioral-Announces-Partnership-with-Cognoa-to-Empower-Parents-and-Enable-Earlier-Diagnosis.html" /> <content type="html"><![CDATA[<p align="left">BALTIMORE, Md. and PALO ALTO, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Qk8hCoTCFfy95csK93ZTHlA-BmkOPtk4yTVjTd61tlXH3vlj4bGO9GGAUQ1yYMFlASlFGfvbA3tFZCWnJotaHoa90sr6VH-_6UYNI0eXPis=" rel="nofollow" target="_blank" title=""><u>LEARN Behavioral</u></a>, the leading network of providers serving children with autism and other special needs, today announces a partnership with digital behavioral health company, <a href="https://www.globenewswire.com/Tracker?data=5URUy4-etQ3vUuE0vDDTKemx-MuLjQ8HYfoqAZwilr0NzmUbdACXwug3E6nSTn4JCMvE-fxEX2JbqK2zlnrv4w==" rel="nofollow" target="_blank" title=""><u>Cognoa, Inc</u></a>., designed to improve the timeliness of care and give more children the greatest opportunity for improved outcomes. Cognoa’s solution will be deployed in nine regions within the LEARN network, including several through Autism Spectrum Therapies (AST), LEARN’s largest provider of Applied Behavior Analysis (ABA) treatment. In total, LEARN serves more than 4,000 families annually across the country.<br></p>]]></content> <dc:identifier>1652376</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Cognoa</dc:contributor> <dc:modified>Thu, 15 Nov 2018 14:04 GMT</dc:modified> <dc:subject>Partnerships</dc:subject> <dc:keyword>Cognoa</dc:keyword> <dc:keyword>child health</dc:keyword> <dc:keyword>child development</dc:keyword> <dc:keyword>LEARN Behavioral</dc:keyword> <dc:keyword>autism</dc:keyword> <dc:keyword>autism spectrum disorder</dc:keyword> <dc:keyword>Enterprise</dc:keyword> </entry> </feed>